Legal Science, LLC (LS) supports researchers and policy advocates in the fights against opioid addiction with our product PDAPS, the Prescription Drug Abuse Policy System.

Please contact us for full details on subscribing to updates on PDAPS.

Prescription Drug Abuse Policy System - PDAPS - Powered by MonQcle

Prescription Drug Abuse Policy System

PDAPS is being developed by Legal Science to provide greater insights into opioid and other drug-related policies.

Sarah B. Klieger, Abraham Gutman, Leslie Allen, Rosalie Liccardo Pacula, Jennifer K. Ibrahim, Scott Burris

Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries

Addiction (21 July 2017)

Thomas C. Buchmueller, Colleen Carey

The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare

National Bureau of Economic Research (23 May 2017)

Daniel I. Rees, Joseph J. Sabia, Laura M. Argys, Joshua Latshaw, Dhaval Dave

With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths

National Bureau of Economic Research (17 February 2017)

Bryce Pardo

Do more robust prescription drug monitoring programs reduce prescription opioid overdose?

Addiction (8 February 2017)

Rosalie Liccardo Pacula

Testimony presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on January 25, 2017.

Regulatiing Medical Marijuana Markets (25 January 2017)

Stephen W. Patrick, Carrie E. Fry, Timothy F. Jones, Melinda B. Buntin

Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates.

Health Affairs (July 2016)

Lainie Rutkow, Hsien-Yen Chang, Matthew Daubresse, et al

Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use

JAMA Internal Medicine (October 2015)

Traci C. Green, et al

Discrepancies in addressing overdose prevention through prescription monitoring programs.

Drug & Alcohol Dependence (August 2015)

Lainie Rutkow, Lydia Turner, Eleanor Lucas, Catherine Hwang, G. Caleb Alexander

Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.

Health Affairs (March 2015)